• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,970.48 -499.63
( -0.64%)
Global Indices
Nasdaq
52,245.67 385.41
(0.74%)
Dow Jones
7,529.66 65.38
(0.88%)
Hang Seng
66,064.76 1,923.64
(3.00%)
Nikkei 225
10,580.59 55.83
(0.53%)
Forex
USD-INR
96.43 0.01
(0.01%)
EUR-INR
110.17 -0.09
(-0.08%)
GBP-INR
129.67 0.03
(0.02%)
JPY-INR
0.59 0.00
(0.01%)

EQUITY - MARKET SCREENER

Max Financial Services Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
500271
INE180A01020
195.5527124
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MFSL
0
53070.02
EPS(TTM)
Face Value()
Div & Yield %
0.17
2
0
 

semac construction ltd
Strides Pharma Science consolidated net profit rises 54.45% in the March 2026 quarter
May 18,2026
Net profit of Strides Pharma Science rose 54.45% to Rs 126.94 crore in the quarter ended March 2026 as against Rs 82.19 crore during the previous quarter ended March 2025. Sales rose 11.18% to Rs 1323.47 crore in the quarter ended March 2026 as against Rs 1190.39 crore during the previous quarter ended March 2025.

For the full year,net profit declined 84.52% to Rs 556.19 crore in the year ended March 2026 as against Rs 3593.46 crore during the previous year ended March 2025. Sales rose 6.43% to Rs 4858.68 crore in the year ended March 2026 as against Rs 4565.34 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1323.471190.39 11 4858.684565.34 6
OPM %18.1118.30 -19.0417.58 -
PBDT207.71182.66 14 897.93614.52 46
PBT154.46133.80 15 695.53422.26 65
NP126.9482.19 54 556.193593.46 -85